Skip to main content
Elliot Norry, MD, Internal Medicine, Philadelphia, PA

Elliot Norry MD FACP

Gastroenterology


Adaptimmune, Chief Medical Officer

Join to view full profile
  • 351 Rouse BlvdPhiladelphia, PA 19112

  • Phone+1 215-825-9260

Dr. Norry is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Gastroenterology, 1993 - 1995
  • Temple University Hospital
    Temple University HospitalResidency, Internal Medicine, 1989 - 1992
  • New York University School of Medicine
    New York University School of MedicineClass of 1989

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1991 - 2026

Publications & Presentations

PubMed

Journal Articles

  • Fludarabine and Neurotoxicity in Engineered T-cell Therapy  
    Elliot Norry, Crystal L Mackall, Nature

Press Mentions

  • Data from Cohort 1 of SPEARHEAD-1 Trial at CTOS Continue to Support BLA Submission for Afami-Cel in Synovial Sarcoma - Response Rate and Durability Remain Consistent
    Data from Cohort 1 of SPEARHEAD-1 Trial at CTOS Continue to Support BLA Submission for Afami-Cel in Synovial Sarcoma - Response Rate and Durability Remain ConsistentNovember 18th, 2022
  • Adaptimmune Reports Positive Results from Its Pivotal SPEARHEAD-1 Trial in Patients with Synovial Sarcoma and MRCLS at CTOS
    Adaptimmune Reports Positive Results from Its Pivotal SPEARHEAD-1 Trial in Patients with Synovial Sarcoma and MRCLS at CTOSNovember 11th, 2021
  • Adaptimmune to Present Data Updates at Upcoming CTOS and SITC Meetings
    Adaptimmune to Present Data Updates at Upcoming CTOS and SITC MeetingsOctober 5th, 2021

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: